Overview of UTINON DHB 200 – Dihydroboldenone Cypionate
UTINON DHB 100 – Dihydroboldenone Cypionate is the 5-alpha-reduced metabolite of Boldenone. While Boldenone requires conversion by the 5-alpha-reductase enzyme to become more potent, DHB is already in this reduced form, providing a more powerful anabolic effect with a faster onset of action. Unlike many other steroids, DHB does not aromatize into estrogen, making it a preferred choice for those seeking lean muscle gains without water retention or estrogenic side effects.
Pharmacological category
- Pharmacological Category: Anabolic-androgenic steroid
- Anabolic Activity Index: 200%
- Androgenic Activity Index: 100%
Mechanism of action
Dihydroboldenone Cypionate is a potent anabolic steroid that binds directly to the androgen receptor without the need for enzymatic conversion. Because it cannot be aromatized, it does not cause estrogen-related side effects such as gynecomastia or edema. It promotes significant protein synthesis and nitrogen retention, leading to the development of high-quality, lean muscle tissue. It is particularly valued for its ability to increase strength and muscle hardness while maintaining a dry physique.
Side effects
Due to its nature as a DHT derivative, DHB carries a higher risk of androgenic side effects compared to Boldenone, including acne and accelerated male pattern baldness in predisposed individuals. However, it is not hepatotoxic (non-liver toxic) as it is an injectable ester. Because it does not aromatize, users should be mindful of maintaining a baseline of estrogen for joint health and overall well-being when using DHB in a cycle.
Dosage recommendations
Dihydroboldenone Cypionate is administered via intramuscular injection.
- Effective Dose: 200‑600 per week
As with any anabolic steroid, it is important to approach DHB with caution and under proper guidance to minimize potential risks and manage hormonal balance.